Smart thermometer put to the test: can it accurately detect fever?
NCT ID NCT06637878
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study checked how well the Withings BeamO (SCT02) smart thermometer measures body temperature compared to a standard reference device. A total of 118 people took part. The goal was to see if the new device gives consistent and accurate readings for detecting fever.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Withings BeamO (SCT02) smart thermometer
- What this could lead to
- If accurate, this device could provide a reliable way to check for fever at home using a smart thermometer.
- What could go wrong
- This is a small, completed validation study, not a treatment trial. Results may not reflect real-world use or accuracy in all age groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
118 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Jan 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria 1. Consent: Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form. 2. Age: Participant age is among the categories 3. Compliance: Understands and is willing, able and likely to comply with all study procedures and restrictions. Exclusion Criteria 1. Personnel: An employee of the sponsor or the study site or members of their immediate family. 2. Medical Condition: 1. Preterm infants (current age plus length of gestation is less than 40 weeks) 2. Has taken antipyretic in previous 2 hours 3. Inflammation at the measurement site 4. Medical conditions that affect temperature readings (barbiturates, thyroid, antipsychotics, recent immunizations)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fever are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Diverse Clinical Research
Miami, Florida, 33175, United States
-
Dragonfly Primary Care
Indianapolis, Indiana, 46237, United States
-
Integrated Family Care
Cincinnati, Ohio, 45206, United States
-
New York City Health and Hospitals Corporation
New York, New York, 10029, United States
-
SES
Mason, Ohio, 45040, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden gut inflammation may drive familial mediterranean fever
- Can a Stick-On sensor replace the thermometer?
- Color-Coded triage: a quick way to spot sick kids?
- Could letting fever run its course help brain injury patients?
- New dissolving paracetamol tablet put to the test
- Blood test may spot hidden infections in sick kids